BRPI0611316B8 - processos para a preparação, separação ou purificação de fosfatidilserina - Google Patents

processos para a preparação, separação ou purificação de fosfatidilserina

Info

Publication number
BRPI0611316B8
BRPI0611316B8 BRPI0611316A BRPI0611316A BRPI0611316B8 BR PI0611316 B8 BRPI0611316 B8 BR PI0611316B8 BR PI0611316 A BRPI0611316 A BR PI0611316A BR PI0611316 A BRPI0611316 A BR PI0611316A BR PI0611316 B8 BRPI0611316 B8 BR PI0611316B8
Authority
BR
Brazil
Prior art keywords
phosphatidylserine
purification
separation
processes
preparation
Prior art date
Application number
BRPI0611316A
Other languages
English (en)
Inventor
Maria Zanellato Anna
Gambillara Antonio
Pittarello Mara
Vaccaro Susanna
Original Assignee
Fidia Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farm Spa filed Critical Fidia Farm Spa
Publication of BRPI0611316A2 publication Critical patent/BRPI0611316A2/pt
Publication of BRPI0611316B1 publication Critical patent/BRPI0611316B1/pt
Publication of BRPI0611316B8 publication Critical patent/BRPI0611316B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00Phosphatide compositions for foodstuffs, e.g. lecithin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/06Alanine; Leucine; Isoleucine; Serine; Homoserine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

processo para a preparação e isolamento de fosfatídeos, suas composições farmacêuticas e respectivos usos. a presente invenção refere-se ao processo para a preparação de fosfatidilserina de fórmula ch2or1 chor2 ch2o-p(=o)-och2-ch(nh2)- cooh x em que r1 e r2 independentemente uma acila c10-c30 saturada, monoinsaturada ou poliinsaturada, x = oh ou om onde m = metal alcalino ou alcalino terroso, amônio, alquliamônio (incluindo o sal interno) incluindo a reação de transfosfatidilação entre fosfatidilcolina da fórmula geral ch2or1 chor2 ch2o-p(=o)-0r3 x em que r1 e r2 e x possuem os significados especificados acima, r3 = ch2-ch2- nh2 ou ch2-ch2-n+(ch3)3 e serina na forma d, l ou racêmica catalisada pela enzima fosfolipase d (pld), caracterizado pelo fato de que dita reação é realizada em um meio hidroalcoólico contendo um álcool alifático e na presença de óxido de metal bivalente.
BRPI0611316A 2005-05-30 2006-05-26 processos para a preparação, separação ou purificação de fosfatidilserina BRPI0611316B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IT000164A ITPD20050164A1 (it) 2005-05-30 2005-05-30 Processo per la preparazione e l'isolamento di fosfatidi
ITPD2005A000164 2005-05-30
US70387005P 2005-08-01 2005-08-01
US60/703,870 2005-08-01
PCT/EP2006/005030 WO2006128639A2 (en) 2005-05-30 2006-05-26 Process for the preparation and isolation of phosphatides

Publications (3)

Publication Number Publication Date
BRPI0611316A2 BRPI0611316A2 (pt) 2010-08-31
BRPI0611316B1 BRPI0611316B1 (pt) 2020-04-07
BRPI0611316B8 true BRPI0611316B8 (pt) 2021-05-25

Family

ID=39449427

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0611316A BRPI0611316B8 (pt) 2005-05-30 2006-05-26 processos para a preparação, separação ou purificação de fosfatidilserina

Country Status (18)

Country Link
US (1) US7759095B2 (pt)
EP (2) EP1890706B1 (pt)
JP (1) JP5113042B2 (pt)
KR (1) KR101298560B1 (pt)
CN (1) CN101184494B (pt)
AT (1) ATE546145T1 (pt)
AU (1) AU2006254376B2 (pt)
BR (1) BRPI0611316B8 (pt)
CA (1) CA2610575C (pt)
ES (2) ES2501015T3 (pt)
HK (1) HK1119584A1 (pt)
IL (1) IL187749A (pt)
IT (1) ITPD20050164A1 (pt)
MX (1) MX2007015064A (pt)
NO (1) NO337009B1 (pt)
PL (2) PL2431020T3 (pt)
PT (2) PT1890706E (pt)
WO (1) WO2006128639A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD20050164A1 (it) 2005-05-30 2006-11-30 Fidia Farmaceutici Processo per la preparazione e l'isolamento di fosfatidi
JP2010529237A (ja) 2007-06-05 2010-08-26 バンク オブ カナダ インクまたはトナー組成物、使用方法および当該方法から得られる生産物
CN102485899A (zh) * 2010-12-03 2012-06-06 张永志 一种制备富含多不饱和双键脂肪酰基的磷脂酰丝氨酸的高品质南极磷虾油的方法
CN102439125B (zh) * 2010-12-03 2014-04-30 上海赢贝生物技术有限公司 一种制备富含多不饱和双键脂肪酰基的磷脂酰丝氨酸的高品质南极磷虾油的方法
ITPD20120021A1 (it) 2012-01-26 2013-07-27 Fidia Farmaceutici "nuove composizioni farmaceutiche contenenti fosfatidilserina e curcumina".
CN104327114A (zh) * 2014-11-06 2015-02-04 江南大学 一种磷脂酰丝氨酸的制备方法
CN112352051A (zh) * 2019-12-31 2021-02-09 邦泰生物工程(深圳)有限公司 一种提高磷脂酶d转脂活性的方法以及用其生产磷脂酰丝氨酸的方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869482A (en) * 1972-07-31 1975-03-04 Etapharm Chem Pharm Lab G M B Method of producing highly purified phosphatides
AT315359B (de) * 1972-07-31 1974-05-27 Etapharm Chem Pharm Lab Ges M Verfahren zur Herstellung von hochgereinigten Phosphatiden aus tierischen Organen
JPS63245684A (ja) * 1987-03-31 1988-10-12 Japanese Res & Dev Assoc Bio Reactor Syst Food Ind ホスフアチジン酸誘導体の製造法
DE69011739T2 (de) * 1989-05-26 1995-01-19 Kao Corp Verfahren zur Herstellung von Phosphatidsäure.
IT1260149B (it) * 1992-04-17 1996-03-28 Fidia Spa Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali
JP3053537B2 (ja) * 1994-11-08 2000-06-19 株式会社ヤクルト本社 脳機能改善剤
US5700668A (en) 1995-12-08 1997-12-23 Italfarmaco Sud S.P.A. Process for the industrial preparation of phosphatidylserine
DE19917249C2 (de) 1999-02-26 2001-09-27 Meyer Lucas Gmbh & Co Verfahren zur Herstellung von Phosphatidylserin-Produkten
IT1311929B1 (it) 1999-04-28 2002-03-20 Chemi Spa Procedimento per la preparazione di fosfatidilserine.
DE19926770A1 (de) 1999-06-11 2000-12-14 Basf Ag Nukleinsäurefragment und Vektor, enthaltend eine Halogenase, sowie ein Verfahren zur Halogenierung chemischer Verbindungen
AU780828B2 (en) 1999-06-15 2005-04-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Enzymatic preparation of phospholipids in aqueous media
AU2001261647A1 (en) 2000-05-15 2001-11-26 Identix Incorporated Fingerprint imaging device
JP4298902B2 (ja) 2000-08-09 2009-07-22 株式会社ヤクルト本社 リン脂質の製造法
IT1319679B1 (it) 2000-12-05 2003-10-23 Chemi Spa Processo di purificazione di fosfatidilserina.
ITPD20010031A1 (it) 2001-02-09 2002-08-09 Fidia Farmaceutici Procedimento per la preparazione di fosfatidi puri e loro impiego in campo cosmetico, farmaceutico ed alimentare.
DE10142014B4 (de) 2001-08-28 2004-11-11 Degussa Bioactives Deutschland Gmbh & Co. Kg Verfahren zur Herstellung von Phosphatidylserin
DE10149108A1 (de) * 2001-10-05 2003-04-30 Degussa Bioactives Deutschland Verwendung von Phosphatidylserin zur Behandlung des Aufmerksamkeits-Defizit-Syndroms (ADHS)
US20030124160A1 (en) * 2001-10-12 2003-07-03 Petrescu Stefana M. Targeted drug delivery
DE10217555A1 (de) * 2002-04-19 2004-02-19 Degussa Bioactives Deutschland Gmbh Physiologisch verträgliche, Phospholipid-haltige, stabile und harte Matrix
DE10340740A1 (de) * 2003-09-04 2005-03-31 Degussa Food Ingredients Gmbh Physiologisch aktive Zusammensetzung auf Phosphatidylserin-Basis
DE102004002053A1 (de) * 2004-01-15 2005-08-04 Bioghurt Biogarde Gmbh & Co. Kg Verfahren zur Herstellung von Phosphatidylserin und dessen Reinigung durch Extraktion
ITPD20050164A1 (it) 2005-05-30 2006-11-30 Fidia Farmaceutici Processo per la preparazione e l'isolamento di fosfatidi

Also Published As

Publication number Publication date
CA2610575A1 (en) 2006-12-07
WO2006128639A3 (en) 2007-08-09
AU2006254376B2 (en) 2011-04-21
ATE546145T1 (de) 2012-03-15
JP5113042B2 (ja) 2013-01-09
PL1890706T3 (pl) 2012-07-31
IL187749A (en) 2014-04-30
CN101184494B (zh) 2012-03-21
US20080275006A1 (en) 2008-11-06
US7759095B2 (en) 2010-07-20
BRPI0611316A2 (pt) 2010-08-31
KR20080011678A (ko) 2008-02-05
MX2007015064A (es) 2008-02-19
PT1890706E (pt) 2012-05-25
PT2431020E (pt) 2014-09-16
KR101298560B1 (ko) 2013-08-22
CA2610575C (en) 2014-09-30
PL2431020T3 (pl) 2015-01-30
NO337009B1 (no) 2015-12-21
HK1119584A1 (en) 2009-03-13
EP2431020B1 (en) 2014-07-16
ES2382748T3 (es) 2012-06-13
AU2006254376A1 (en) 2006-12-07
EP1890706A2 (en) 2008-02-27
BRPI0611316B1 (pt) 2020-04-07
EP2431020A1 (en) 2012-03-21
ES2501015T3 (es) 2014-10-01
ITPD20050164A1 (it) 2006-11-30
NO20076158L (no) 2007-11-29
EP1890706B1 (en) 2012-02-22
WO2006128639A2 (en) 2006-12-07
CN101184494A (zh) 2008-05-21
IL187749A0 (en) 2008-04-13
JP2008545420A (ja) 2008-12-18

Similar Documents

Publication Publication Date Title
BRPI0611316B8 (pt) processos para a preparação, separação ou purificação de fosfatidilserina
WO2006101851A3 (en) Microfluidic system
WO2007002890A3 (en) Methods of producing and sequencing modified polynucleotides
EP1915390A4 (en) COMPOSITIONS AND METHODS FOR MONITORING AND MODIFYING PROTEIN FOLDING AND SOLUBILITY
WO2008033575A3 (en) Methods of identifying biochemical pathways
WO2007022459A3 (en) Processes and intermediates
WO2007073424A8 (en) Pure rocuronium bromide
CA2545989A1 (en) Method and device for purifying nucleic acids
HK1158700A1 (en) Methods and compositions for detecting autoimmune disorders
WO2006105483A3 (en) Mutant dna polymerases and methods of use
WO2007008583A3 (en) Improved protein expression comparison assay results and applications
WO2006050260A3 (en) The efficient removal of mercury from flue gases
WO2005103229A3 (en) Transgenomic mitochondria, transmitochondrial cells and organisms, and methods of making and using
WO2006107906A3 (en) Sealing element
WO2006135938A3 (en) Fluorometric method for monitoring a clean-in-place system
WO2006127973A3 (en) Methods for separating and analyzing anionic compounds
WO2007003584A3 (de) Verwendung von zusammensetzungen zur entfernung von silikonverbindungen
EP1893892A4 (en) UNIVERSAL DRIVE OF TRANSISTORART
WO2007023474A3 (en) A cooling device
ATE413413T1 (de) Methode zur produktion von faktor g des pfeilschwanzkrebses (limulus)
HK1104237A1 (en) Small molecules that replace or agonize p53 function
WO2006064517A3 (en) Methods for the purification of 20(s)-camptothecin
WO2006135677A3 (en) Zebrafish assay
WO2006116687A3 (en) Nanoassays
WO2006100021A8 (en) Use of the mst protein for the treatment of a thromboembolic disorder

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23J 7/00 (2006.01), A61K 8/14 (2006.01), A61K 8/5

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 07/04/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/05/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2724 DE 21-03-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.